Separation Agreements in the Pharmaceuticals Industry

356 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (1 contract)
ACELRX PHARMACEUTICALS INC (2)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (1)
Aegerion Pharmaceuticals, Inc. (1)
AEOLUS PHARMACEUTICALS, INC. (3)
AERIE PHARMACEUTICALS INC (2)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (2)
ALIMERA SCIENCES INC (1)
Allergan, plc (3)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (1)
Amylyx Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (3)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (2)
Aquestive Therapeutics, Inc. (2)
Assertio Holdings, Inc. (4)
ATAI Life Sciences B.V. (2)
Athira Pharma, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (8)
AVANIR PHARMACEUTICALS, INC. (2)
AYTU BIOSCIENCE, INC (1)
Baudax Bio, Inc. (1)
Bausch Health Companies Inc. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Boston Therapeutics, Inc. (1)
Cara Therapeutics, Inc. (1)
Cerecor Inc. (4)
CHIASMA, INC (1)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (1)
COGNITION THERAPEUTICS INC (1)
Columbia Care Inc. (1)
ContraVir Pharmaceuticals, Inc. (1)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (4)
CPEX Pharmaceuticals, Inc. (1)
Cure Pharmaceutical Holding Corp. (1)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (4)
Elanco Animal Health Inc (2)
Eloxx Pharmaceuticals, Inc. (1)
ENCYSIVE PHARMACEUTICALS INC (2)
Endo International plc (4)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (4)
Evolus, Inc. (5)
Exactus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (1)
EYETECH PHARMACEUTICALS INC (1)
Fresenius Kabi Pharmaceuticals Holding, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (1)
Harmony Biosciences Holdings, Inc. (2)
HARVEST HEALTH & RECREATION INC. (1)
Horizon Pharma plc (1)
Hoth Therapeutics, Inc. (1)
iANTHUS CAPITAL HOLDINGS, INC. (2)
IMARA Inc. (4)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (6)
Jazz Pharmaceuticals plc (1)
Johnson & Johnson (1)
Kaleido Biosciences, Inc. (1)
KEMPHARM, INC (1)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (6)
Level Brands, Inc. (4)
Lipocine Inc. (2)
Liquidia Corp (1)
Lyra Therapeutics, Inc. (1)
Mallinckrodt (6)
Merck (17)
MJ Holdings, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (6)
MYnd Analytics, Inc. (3)
Nabriva Therapeutics plc (7)
NEKTAR THERAPEUTICS (9)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (3)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (4)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (2)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (5)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (1)
Organon & Co. (2)
Paratek Pharmaceuticals, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (1)
Pfizer (6)
Phathom Pharmaceuticals, Inc. (2)
Phibro Animal Health Corporation (1)
PLx Pharma Inc. (1)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (2)
Recro Pharma, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
Revance Therapeutics, Inc. (5)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (1)
Sagent Pharmaceuticals, Inc. (2)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (2)
scPharmaceuticals Inc. (2)
SenesTech, Inc. (4)
Sienna Biopharmaceuticals, Inc. (4)
SIGA TECHNOLOGIES INC (1)
Sonoma Pharmaceuticals, Inc. (6)
Sucampo Pharmaceuticals, Inc. (4)
SYNERGY PHARMACEUTICALS, INC. (3)
Tarsus Pharmaceuticals, Inc. (1)
Terns Pharmaceuticals, Inc. (1)
Terra Tech Corp. (6)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (2)
The Medicines Company (1)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (2)
Tilray, Inc. (4)
TILT Holdings Inc. (2)
Upjohn Inc (8)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Vallon Pharmaceuticals, Inc. (1)
Ventyx Biosciences, Inc. (1)
VIA Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (1)
Virpax Pharmaceuticals, Inc. (1)
Vitality Biopharma, Inc. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (3)
Zomedica Pharmaceuticals Corp. (4)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Separation Agreement and General Release by and among the Company, iAnthus Capital Management, LLC and Robert Galvin dated October 11, 2023 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on March 28, 2024)
Separation and Release of Claims Agreement dated March 13, 2024 between The Cannabist Company Holdings Inc. and Nicholas Vita (attached herein as Exhibit 10.24 of the Registrant's... (Columbia Care Inc., Filed With SEC on March 13, 2024)
Separation Agreement, effective December 14, 2023, between CorMedix Inc. and Phoebe Mounts (CorMedix Inc., Filed With SEC on March 12, 2024)
Separation Agreement and Release with Sanjeev Narula, dated December 15, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Separation Agreement and Release with Anthony Mauro, dated October 20, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Separation Agreement dated February 23, 2024 by and between Revance Therapeutics, Inc. and Dustin Sjuts (Revance Therapeutics, Inc., Filed With SEC on February 28, 2024)
Separation Agreement and Release, dated November 22, 2023, by and between the Registrant and William J. Sandborn (Ventyx Biosciences, Inc., Filed With SEC on February 27, 2024)
Separation Agreement, Waiver, and Release, dated as of February 4, 2024, by and between the Registrant and Douglas Manion (Aclaris Therapeutics, Inc., Filed With SEC on February 27, 2024)
Merck & Co., Inc. U.S. Separation Benefits Plan (amended and restated as of January 1, 2019) as further amended by Amendments 2019-1 (as of December 19, 2019), 2020-1 (as of... (Merck, Filed With SEC on February 26, 2024)
Form of Executive Separation Agreement (Organon & Co., Filed With SEC on February 26, 2024)
Separation Agreement between Registrant and Margaret Olinger dated December 31, 2023 (Amylyx Pharmaceuticals, Inc., Filed With SEC on February 22, 2024)
Separation Agreement between Mr. Stephen Bardin and atai Life Sciences N.V., dated February 6, 2024 (ATAI Life Sciences B.V., Filed With SEC on February 6, 2024)
Separation Agreement and General Release, dated January 2, 2024, by and between Alimera Sciences, Inc. and Russell Skibsted (ALIMERA SCIENCES INC, Filed With SEC on January 4, 2024)
Separation and Release Agreement, by and between Theseus Pharmaceuticals, Inc. and David Kerstein, M.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Separation and Release Agreement, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson, Ph.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Separation Agreement between Terns, Inc. and Senthil Sundaram dated August 2, 2023 (Terns Pharmaceuticals, Inc., Filed With SEC on November 14, 2023)
Separation Agreement dated September 21, 2023, between Vireo Health, Inc., and John Heller (Vireo Health International, Inc., Filed With SEC on November 14, 2023)
Employment Mutual Separation Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Paul M. Rivard (Akers Biosciences, Inc., Filed With SEC on November 14, 2023)
Transition and Separation Agreement, dated August 17, 2023, by and between Agile Therapeutics, Inc. and Jason Butch (AGILE THERAPEUTICS INC, Filed With SEC on November 9, 2023)
Separation Agreement, dated May 4, 2023, by and between Registrant and Leonard Greenstein (Tarsus Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
Employment Separation and Release Agreement effective as of June 19, 2023 by and between Nektar Therapeutics and Jillian B. Thomsen (NEKTAR THERAPEUTICS, Filed With SEC on August 9, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Separation Agreement dated June 28, 2023 by and between TILT Holdings Inc. and Dana Arvidson (TILT Holdings Inc., Filed With SEC on July 5, 2023)
Separation and Mutual Release Agreement (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Separation agreement, dated June 18, 2023 by and between Virpax Pharmaceuticals, Inc. and Christopher Chipman (Virpax Pharmaceuticals, Inc., Filed With SEC on June 21, 2023)
Separation Agreement and Release between John Temperato and 9 Meters Biopharma, Inc., dated May 29, 2023 (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on May 30, 2023)
Separation Agreement, dated March 31, 2023, by and between Detlef Albrecht and Satsuma Pharmaceuticals, Inc (Satsuma Pharmaceuticals, Inc., Filed With SEC on May 11, 2023)
Separation Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc (Johnson & Johnson, Filed With SEC on May 8, 2023)
Separation Agreement dated April 21, 2023 by and between TILT Holdings Inc. and Gary F. Santo, Jr (TILT Holdings Inc., Filed With SEC on April 25, 2023)
Separation Agreement between SenesTech, Inc. and Nicole Williams dated April 21, 2023 (SenesTech, Inc., Filed With SEC on April 24, 2023)
Separation Agreement, dated April 21, 2023, by and between GRI Bio, Inc. and David Baker (Vallon Pharmaceuticals, Inc., Filed With SEC on April 21, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Nabriva Therapeutics plc, Filed With SEC on April 17, 2023)
Separation Agreement and General Release, dated April 14, 2023, by and between John Kozlowski and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on April 14, 2023)
Separation Agreement, dated March 16, 2023, between Zomedica Inc. and Ann Marie Cotter (Zomedica Pharmaceuticals Corp., Filed With SEC on March 17, 2023)
Michael Gray Separation Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Rahul Ballal Separation Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Separation Agreement with Michael Goettler, dated February 24, 2023 (Upjohn Inc, Filed With SEC on February 27, 2023)
Merck & Co., Inc. U.S. Separation Benefits Plan (amended and restated as of January 1, 2019) as further amended by Amendments 2019-1 (as of December 19, 2019), 2020-1 (as of... (Merck, Filed With SEC on February 24, 2023)
Separation Agreement and General Release, dated as of December 9, 2022, by and between the Registrant and Frank Ruffo (Aclaris Therapeutics, Inc., Filed With SEC on February 23, 2023)